Supply Chain

Senator Joe Manchin's (D-W.Va.) ties to the congressional scrutiny surrounding the skyrocketing price of EpiPens runs deeper than just politics. His daughter, Heather Bresch, is CEO of Mylan, the company behind the epinephrine injection, reports The Washington Post.

Getting your master's degree in global sourcing

The Food and Drug Administration reached an agreement with representatives of the medical device industry for proposed recommendations of the medical device user fee program.

In June, the CDC recommended against using AstraZeneca's nasal flu vaccine, FluMist, citing a lack of evidence regarding the vaccine's efficacy. FluMist's absence from the American market is causing some physicians to worry about a potential flu vaccine shortage.

The Food and Drug Administration submitted an annual report to Congress regarding the use of citizen petitions that allow the general public to ask the agency to refrain from approving a generic drug or biosimilar over potential health concerns, reported…

Senator Bernie Sanders (D-Vt.) responded to news of Pfizer's $14 billion acquisition of Medivation by calling on the drug industry to lower the cost of prescription drugs, reported CNN.

The Food and Drug Administration granted de novo clearance for ImPACT, a device used to assess cognitive function following possible concussion or brain injury.

International investors are increasingly bidding for biomedical laboratories in Boston in what they see as an opportunity to profit from increasing property values and rent, according to The Boston Globe.

In the fourth quarter of fiscal year 2016, Charlotte, N.C.-based Premier saw net revenue increase 13 percent from the same period last year to $301.4 million. Most notably, its supply chain services segment revenue rose 11 percent and its performance…

Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) wants answers —specifically, to why the price of EpiPens has jumped 400 percent since 2007, reported The Hill.